Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait
UConn Health · NCT07083531
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 50+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- August 23, 2022
- Record last updated
- July 24, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a cross-sectional, clinical research study comparing postmenopausal women of African Descent (AD) with different hemoglobin genotypes: normal and sickle cell trait (SCT). This research study has two purposes. The first purpose is to determine whether having SCT is a risk factor for the development of bone thinning in older women. The second purpose is to investigate whether women with SCT have reduced muscle function and increased frailty compared to women without SCT. The investigators estimate enrolling 50 female volunteers who are at least 50 years old and have not had a menstrual period for at least 12 consecutive months. Volunteers need not know whether they have SCT as this will be evaluated as part of the study.
Being studied: Healthy volunteers without SCT; Healthy volunteers with SCT
Conditions: Sickle Cell Disease; Sickle Cell Trait
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Female of African Decent.
- Age 50 years or older.
- Lack of menstrual period for at least 12 consecutive months
Exclusion Criteria
- Taking medications known to influence bone metabolism (e.g., glucocorticoids, hormonal therapy, cancer or chemotherapy meds, anti-resorptive medications or anabolic therapies).
- Known metabolic bone disorder (e.g., uncontrolled thyroid disease, hyperparathyroidism, Vitamin D deficiency)
- Taking an investigational drug
- Documented sickle cell disease
Recruiting US locations
UConn Health
Farmington, CT 06030
Site contact: Sasia Jones, MPH · 860.679.7879 · Sajones@uchc.edu
Study contacts (from the official record)
- Zoe Green, BS · 860.679.4656 · zgreen@uchc.edu
Similar studies in Connecticut
All healthy volunteers studies in Connecticut →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
Pfizer
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersEarly Phase 1Overnight stay mentioned
Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder
Yale University
- Location
- New Haven, CT
- Eligibility basics
- Ages 21–70
- RecruitingHealthy volunteersPhase 1
MK-0947 PN-002: An Open-label Study to Evaluate Brain α-synuclein Deposition Using Positron Emission Tomography (PET) and [¹⁸F]MK-0947 in Participants With Parkinson's Disease (PD)
XingImaging, LLC
- Location
- New Haven, CT
- Eligibility basics
- Ages 40–80
- RecruitingHealthy volunteersEarly Phase 1
A Study of the Pharmacokinetics, Biodistribution and Dosimetry of Granzyme-B Targeted [Cu-64]-Labeled PET Radiotracers in Adult Healthy Volunteers
Ratio Therapeutics, Inc.
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–60